CME Selling And Marketing Expenses vs Net Income Analysis
CME Stock | USD 213.14 0.41 0.19% |
CME financial indicator trend analysis is way more than just evaluating CME Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CME Group is a good investment. Please check the relationship between CME Selling And Marketing Expenses and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Selling And Marketing Expenses vs Net Income
Selling And Marketing Expenses vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CME Group Selling And Marketing Expenses account and Net Income. At this time, the significance of the direction appears to have strong relationship.
The correlation between CME's Selling And Marketing Expenses and Net Income is 0.6. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Net Income in the same time period over historical financial statements of CME Group, assuming nothing else is changed. The correlation between historical values of CME's Selling And Marketing Expenses and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of CME Group are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Selling And Marketing Expenses i.e., CME's Selling And Marketing Expenses and Net Income go up and down completely randomly.
Correlation Coefficient | 0.6 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Selling And Marketing Expenses
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in CME Group financial statement analysis. It represents the amount of money remaining after all of CME Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most indicators from CME's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CME Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At present, CME's Enterprise Value is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.9B | 4.3B | 4.5B | 2.5B | Total Revenue | 4.7B | 5.0B | 5.6B | 3.0B |
CME fundamental ratios Correlations
Click cells to compare fundamentals
CME Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CME fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 75.2B | 124.7B | 196.8B | 174.2B | 129.8B | 136.3B | |
Short Long Term Debt Total | 3.7B | 3.4B | 3.4B | 3.4B | 3.9B | 2.4B | |
Other Current Liab | 38.5B | 88.1B | 159.6B | 132.2B | 93.3B | 98.0B | |
Total Current Liabilities | 38.5B | 88.2B | 160.4B | 137.7B | 93.4B | 98.1B | |
Total Stockholder Equity | 26.1B | 26.3B | 27.4B | 26.9B | 26.7B | 17.6B | |
Other Liab | 6.2B | 6.7B | 6.3B | 5.7B | 6.6B | 6.2B | |
Property Plant And Equipment Net | 544M | 579.2M | 505.3M | 455.5M | 681.5M | 483.4M | |
Net Debt | 2.2B | 1.8B | 610.2M | 718.3M | 966.7M | 843.5M | |
Retained Earnings | 5.0B | 5.0B | 5.2B | 4.7B | 4.5B | 3.0B | |
Accounts Payable | 61.9M | 69.3M | 48.8M | 121.4M | 90.6M | 51.7M | |
Cash | 1.6B | 1.6B | 2.8B | 2.7B | 2.9B | 3.1B | |
Non Current Assets Total | 35.6B | 35.4B | 35.0B | 35.1B | 34.8B | 24.0B | |
Non Currrent Assets Other | 2.1B | 2.0B | 3.3B | (3.1B) | 514.1M | 1.0B | |
Other Assets | 545.9M | 7.3B | 3.3B | 574M | 134.4M | 127.7M | |
Long Term Debt | 3.7B | 3.4B | 2.7B | 3.4B | 3.4B | 2.5B | |
Cash And Short Term Investments | 1.6B | 1.7B | 2.9B | 2.8B | 3.0B | 2.7B | |
Net Receivables | 491.8M | 461.3M | 434.5M | 483.2M | 1.3B | 1.3B | |
Common Stock Shares Outstanding | 358.2M | 358.5M | 358.9M | 359.2M | 359.5M | 311.9M | |
Liabilities And Stockholders Equity | 75.2B | 124.7B | 196.8B | 174.2B | 129.8B | 136.3B | |
Non Current Liabilities Total | 10.5B | 10.1B | 9.0B | 9.6B | 9.6B | 7.4B | |
Other Current Assets | 360.1M | 302M | 423M | 524.9M | (4.3B) | (4.1B) | |
Other Stockholder Equity | 21.1B | 21.2B | 22.2B | 22.3B | 22.3B | 14.5B | |
Total Liab | 49.1B | 98.3B | 169.4B | 147.3B | 103.1B | 108.3B | |
Property Plant And Equipment Gross | 544M | 579.2M | 505.3M | 455.5M | 1.3B | 1.4B | |
Total Current Assets | 39.6B | 89.3B | 161.8B | 139.1B | 94.9B | 99.6B | |
Accumulated Other Comprehensive Income | 3.4M | 134.9M | 53.5M | (133.3M) | (55.6M) | (52.8M) | |
Property Plant Equipment | 544M | 579.2M | 505.3M | 837.6M | 963.2M | 490.1M | |
Short Term Investments | 83.2M | 100.9M | 115M | 96M | 111.7M | 106.1M | |
Inventory | 37.1B | 86.8B | 158.0B | 135.3B | 155.5B | 163.3B | |
Short Term Debt | 49.7M | 52.2M | 749.4M | 16M | 55.1M | 52.3M | |
Intangible Assets | 22.3B | 22.0B | 20.7B | 20.4B | 20.2B | 18.4B | |
Good Will | 10.7B | 10.8B | 10.5B | 10.5B | 10.5B | 8.9B | |
Retained Earnings Total Equity | 4.9B | 5.0B | 5.0B | 5.2B | 5.9B | 3.7B | |
Deferred Long Term Liab | 5.7B | 5.6B | 5.6B | 5.4B | 6.2B | 4.7B | |
Net Tangible Assets | (6.9B) | (6.5B) | (3.8B) | (4.0B) | (4.7B) | (4.9B) | |
Long Term Debt Total | 3.8B | 3.7B | 3.4B | 2.7B | 3.1B | 2.9B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Dividend Share 4.45 | Earnings Share 8.79 | Revenue Per Share 15.638 | Quarterly Revenue Growth 0.032 |
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.